NTxBio
PrivateLast Round
Grant
May 14, 2025
Total Funding Raised
$77.32M
Company Overview
NTxBio is a biotechnology company that provides a cell-free biomanufacturing platform for the scalable production of high-quality RNA and protein therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NTxBio Comparables
Compare NTxBio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tierra Biosciences | 79% | |
| Liberum Biotech | 79% | |
| Centillion Biosciences Inc. | 76% |
NTxBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 14, 2025 | ||||
| Debt | Dec 4, 2024 | ||||
| Series B | Nov 16, 2023 | ||||
| Grant | Feb 25, 2020 | ||||
| Series A | Feb 25, 2020 |
NTxBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Series A, Series B |
| Texas Enterprise Fund | Grant |
| New Mexico Economic Development Department | Grant |
| Anzu Partners | Series B, Series A |
| New Mexico Economic Development Department | Grant |
| BlueStone Venture Partners | Series B |
| JPMorgan Chase & Co. | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 15, 2025
Opening a new $31 million facility and adding 170 jobs in Texas.
- May 14, 2025
$1.48M grant from Texas Enterprise Fund
Recent news
Latest coverage and updates
- is_developingAug 19, 2026
Ntxbio is developing innovative systems like NTxscribe and NTxpress.
- launchesJul 7, 2026
Ntxbio launched NTxscribe FLEX system on Jul 7th '26.
NTxBio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NTxBio's valuation, stock price, and market status.
Is NTxBio a public or private company?
NTxBio is a private company.
What is the current stock price of NTxBio?
NTxBio is a private company with no public stock price. No recent secondary market data is available.
How much is NTxBio worth (valuation)?
Valuation information for NTxBio is not publicly available.
Can I buy NTxBio stock?
NTxBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NTxBio's last funding round?
NTxBio's most recent funding round was Grant on May 14, 2025.
Who are the main investors in NTxBio?
Key investors in NTxBio include RA Capital Management, Anzu Partners, J.P. Morgan.
Will NTxBio IPO soon?
No public IPO plans have been announced for NTxBio.
How can I track NTxBio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NTxBio's secondary market activity and sign up for updates.